Reuters Highlights Washington Albertsons Opioid Trial Following National Settlement

Reuters recently highlighted the start of Washington State’s trial against Albertsons, one of the remaining opioid cases proceeding after the company’s previously announced $774 million nationwide settlement. The state alleges Albertsons’ pharmacy practices contributed to the opioid epidemic by failing to adequately identify and address warning signs associated with opioid prescriptions. Albertsons denies the allegations.

Levin Papantonio attorney Jeff Gaddy represents the State of Washington in the case. During opening statements, Gaddy argued that Albertsons’ corporate policies created working conditions that made it difficult for pharmacists to fulfill their professional responsibilities.

“[Albertsons] fostered a work environment from top to bottom that was chaotic, stressful, and hostile, and where folks felt like they were grinded down to a nub,” Gaddy said. “Albertsons substantially contributed to the opioid epidemic here within the state, and it needs to be cleaned up.”

According to Reuters, Washington alleges Albertsons emphasized prescription volume while failing to provide pharmacists with the staffing and support necessary to identify potential warning signs of opioid misuse or diversion. Albertsons operates approximately 200 pharmacies in Washington, primarily under its Safeway brand.

Washington Attorney General Nick Brown said more than 26,000 Washington residents have died from opioid overdoses since the beginning of the opioid crisis, including more than 7,400 deaths in the past three years alone. The lawsuit seeks to hold Albertsons accountable for its alleged role in contributing to the epidemic within the state.

Albertsons disputes the allegations and maintains that it complied with applicable laws. The trial is expected to continue through early September.

Levin Papantonio has been at the forefront of opioid litigation nationwide, helping secure significant recoveries for states, municipalities, and individuals affected by opioid abuse and addiction. The firm’s attorneys have played a leading role in shaping major opioid litigation across the country.

Related Pages

• Albertsons’ $774 Million Opioid Settlement Signals Continued Accountability for Pharmacy Chains
• Levin Papantonio’s leadership in national opioid litigation